BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17087739)

  • 21. Tumor necrosis factor-alpha is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population.
    Jiménez-Morales S; Velázquez-Cruz R; Ramírez-Bello J; Bonilla-González E; Romero-Hidalgo S; Escamilla-Guerrero G; Cuevas F; Espinosa-Rosales F; Martínez-Aguilar NE; Gómez-Vera J; Baca V; Orozco L
    Hum Immunol; 2009 Apr; 70(4):251-6. PubMed ID: 19480843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin's lymphoma.
    Monne M; Piras G; Palmas A; Arru L; Murineddu M; Latte G; Noli A; Gabbas A
    Am J Hematol; 2004 May; 76(1):14-8. PubMed ID: 15114591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alleles -308A and -1031C in the TNF-alpha gene promoter do not increase the risk but associated with circulating levels of TNF-alpha and clinical features of vivax malaria in Indian patients.
    Sohail M; Kaul A; Bali P; Raziuddin M; Singh MP; Singh OP; Dash AP; Adak T
    Mol Immunol; 2008 Mar; 45(6):1682-92. PubMed ID: 17996942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The -308G/A polymorphism of TNF-alpha influences immunological parameters in old subjects affected by infectious diseases.
    Cipriano C; Caruso C; Lio D; Giacconi R; Malavolta M; Muti E; Gasparini N; Franceschi C; Mocchegiani E
    Int J Immunogenet; 2005 Feb; 32(1):13-8. PubMed ID: 15686588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between non-Hodgkin lymphoma and haplotypes in the TNF region.
    Spink CF; Keen LJ; Mensah FK; Law GR; Bidwell JL; Morgan GJ
    Br J Haematol; 2006 May; 133(3):293-300. PubMed ID: 16643431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
    Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor necrosis factor-alpha --G308A polymorphism in schizophrenia in a Finnish population.
    Hänninen K; Katila H; Rontu R; Mattila KM; Hurme M; Lehtimäki T
    Neurosci Lett; 2005 Sep; 385(1):76-81. PubMed ID: 15927374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity.
    Azmy IA; Balasubramanian SP; Wilson AG; Stephenson TJ; Cox A; Brown NJ; Reed MW
    Breast Cancer Res; 2004; 6(4):R395-400. PubMed ID: 15217507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95.
    Seidemann K; Zimmermann M; Book M; Meyer U; Burkhardt B; Welte K; Reiter A; Stanulla M
    J Clin Oncol; 2005 Nov; 23(33):8414-21. PubMed ID: 16293872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGF-beta1 gene polymorphisms influence the course of the disease in non-Hodgkin's lymphoma patients.
    Mazur G; Bogunia-Kubik K; Wrobel T; Kuliczkowski K; Lange A
    Cytokine; 2006 Feb; 33(3):145-9. PubMed ID: 16524740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of polymorphisms of tumor necrosis factor-alpha and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: study from northern India.
    Mittal RD; Manchanda PK; Bid HK; Ghoshal UC
    J Gastroenterol Hepatol; 2007 Jun; 22(6):920-4. PubMed ID: 17565649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma.
    Fernberg P; Chang ET; Duvefelt K; Hjalgrim H; Eloranta S; Sørensen KM; Porwit A; Humphreys K; Melbye M; Ekström Smedby K
    Cancer Causes Control; 2010 May; 21(5):759-69. PubMed ID: 20087644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans.
    Rodríguez-Carreón AA; Zúñiga J; Hernández-Pacheco G; Rodríguez-Pérez JM; Pérez-Hernández N; Montes de Oca JV; Cardiel MH; Granados J; Vargas-Alarcón G
    J Autoimmun; 2005 Feb; 24(1):63-8. PubMed ID: 15725578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease.
    Wang B; Zhou S; Yang Z; Xie YC; Wang J; Zhang P; Lv Z; Zheng C; Ma X
    J Neurol Sci; 2008 Jul; 270(1-2):148-51. PubMed ID: 18396294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined effect of tumour necrosis factor-alpha and interleukin-13 polymorphisms on bronchial hyperresponsiveness in Korean children with asthma.
    Kim HB; Kang MJ; Lee SY; Jin HS; Kim JH; Kim BS; Jang SO; Lee YC; Sohn MH; Kim KE; Hong SJ
    Clin Exp Allergy; 2008 May; 38(5):774-80. PubMed ID: 18341619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tumor necrosis factor alpha genetic polymorphism as a risk factor in disease].
    Aguillón JC; Cruzat A; Cuenca J; Cuchacovich M
    Rev Med Chil; 2002 Sep; 130(9):1043-50. PubMed ID: 12434654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor alpha gene polymorphism is associated with cerebral infarction.
    Um JY; Kim HM
    Brain Res Mol Brain Res; 2004 Mar; 122(1):99-102. PubMed ID: 14992821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor-alpha promoter -308 A/G polymorphism and rheumatoid arthritis susceptibility: a metaanalysis.
    Lee YH; Ji JD; Song GG
    J Rheumatol; 2007 Jan; 34(1):43-9. PubMed ID: 17143972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
    Kube D; Hua TD; von Bonin F; Schoof N; Zeynalova S; Klöss M; Gocht D; Potthoff B; Tzvetkov M; Brockmöller J; Löffler M; Pfreundschuh M; Trümper L
    Clin Cancer Res; 2008 Jun; 14(12):3777-84. PubMed ID: 18559596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma.
    Wang SS; Cerhan JR; Hartge P; Davis S; Cozen W; Severson RK; Chatterjee N; Yeager M; Chanock SJ; Rothman N
    Cancer Res; 2006 Oct; 66(19):9771-80. PubMed ID: 17018637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.